½ÃÀ庸°í¼­
»óǰÄÚµå
1481327

¼¼°èÀÇ ÇÚµåÇïµå ½ÉÀåÃÊÀ½ÆÄ µð¹ÙÀ̽º ½ÃÀå : Á¦Ç°º°, ¸®µå À¯Çüº°, ÃÖÁ¾ ¿ëµµº°, ¿¹Ãø(2024-2032³â)

Handheld Echocardiography Devices Market - By Product (Diagnostics [Resting, Stress], Monitoring [Wearable, MCT]), Lead Type (Single Lead, 3 Lead, 6 Lead, 12 Lead), End-use (Hospitals, Clinics, Diagnostic Centers, ASCs) - Global Forecast, 2024 - 2032

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Global Market Insights Inc. | ÆäÀÌÁö Á¤º¸: ¿µ¹® 163 Pages | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

¼¼°èÀÇ ÇÚµåÇïµå ½ÉÀåÃÊÀ½ÆÄ µð¹ÙÀ̽º ½ÃÀåÀº ½ÉÇ÷°üÁúȯ(CVD)ÀÇ À¯º´·ü »ó½Â, ÇÚµåÇïµå ½ÉÀåÃÊÀ½ÆÄ µð¹ÙÀ̽ºÀÇ ±â¼ú Áøº¸, ½ÉÁúȯÀÇ Á¶±â ¹ß°ß°ú ¸ð´ÏÅ͸µ¿¡ ´ëÇÑ ÀǽÄÀÇ Çâ»ó µîÀ» ¹è°æÀ¸·Î 2024-2032³â¿¡ CAGR 4.5%·Î ¼ºÀåÇÕ´Ï´Ù.

WHO¿¡ µû¸£¸é ½ÉÇ÷°ü ÁúȯÀº ¸Å³â ¾à 1,790¸¸ ¸íÀÇ ¸ñ¼ûÀ» ¾Ñ¾Æ°¡´Â ¼¼°è ÁÖ¿ä »ç¸Á ¿øÀÎÀ¸·Î, CVD´Â Àü ¼¼°è »ç¸Á·üÀÇ »ó´ç ºÎºÐÀ» Â÷ÁöÇϰí ÀÖÀ¸¸ç, Á¶±â ¹ß°ß°ú °³ÀÔÀ» °¡´ÉÇÏ°Ô ÇÏ´Â È¿À²ÀûÀÎ Áø´Ü ÅøÀÌ Àý½ÇÈ÷ ¿ä±¸µÇ°í ÀÖ½À´Ï´Ù. ÇÚµåÇïµå ½ÉÀåÃÊÀ½ÆÄ µð¹ÙÀ̽º´Â ÀÇ·áÁøÀÌ Àû½Ã¿¡ ½ÉÀåÀ» Æò°¡ÇÒ ¼ö ÀÖ´Â ÈÞ´ë°¡ °£ÆíÇϰí Á¢±ÙÇϱ⠽¬¿î ¼Ö·ç¼ÇÀ» Á¦°øÇÏ¿© CVD¸¦ »çÀü¿¡ °ü¸®ÇÒ ¼ö ÀÖµµ·Ï µ½½À´Ï´Ù. ÁÂ½Ä »ýȰ ½À°ü, °Ç°­¿¡ ÇØ·Î¿î ½Ä½À°ü, °í·ÉÈ­ µîÀÇ ¿äÀÎÀ¸·Î ÀÎÇØ Àü ¼¼°è¿¡¼­ ½ÉÇ÷°ü ÁúȯÀÇ ºÎ´ãÀÌ °è¼Ó Áõ°¡ÇÔ¿¡ µû¶ó ÇÚµåÇïµå ½ÉÀåÃÊÀ½ÆÄ µð¹ÙÀ̽º¿¡ ´ëÇÑ ¼ö¿ä°¡ ±ÞÁõÇÏ¿© ÇâÈÄ ¼ö³â°£ ½ÃÀå ¼ºÀåÀ» ÁÖµµÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

ÇÚµåÇïµå ½ÉÀåÃÊÀ½ÆÄ µð¹ÙÀ̽º »ê¾÷Àº Á¦Ç°, ¸®µå À¯Çü, ÃÖÁ¾ ¿ëµµ ¹× Áö¿ªº°·Î ºÐ·ùµË´Ï´Ù.

½ÉÀåÃÊÀ½ÆÄ µð¹ÙÀ̽º´Â ÁßȯÀڽǿ¡¼­ ¿Ü·¡ Áø·á¼Ò±îÁö ´Ù¾çÇÑ ÀÓ»ó ȯ°æ¿¡¼­ ½ÉÀå ±â´ÉÀ» Áö¼ÓÀûÀ¸·Î ¸ð´ÏÅ͸µÇÒ ¼ö ÀÖ°Ô ÇÔÀ¸·Î½á 2032³â±îÁö ¸ð´ÏÅ͸µ ºÎ¹®ÀÌ Å« ¼ºÀåÀ» ±â·ÏÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¼¾¼­ ±â¼ú°ú µ¥ÀÌÅÍ ºÐ¼®ÀÇ ¹ßÀüÀ¸·Î ½É¹ÚÃâ·®, ¹ÚÃâ·®, ¹ÚÃâ·ü, ÆÇ¸· ±â´É ÃøÁ¤ µî Á¾ÇÕÀûÀÎ Ç÷ÇൿÅ Æò°¡°¡ °¡´ÉÇÑ ÇÚµåÇïµå ±â±âÀÇ °³¹ßÀÌ °¡´ÉÇØÁü¿¡ µû¶ó ÀÌ ºÎ¹®ÀÇ ¼ºÀåÀ» °¡¼ÓÇϰí ÀÖ½À´Ï´Ù.

ÇÚµåÇïµå ½ÉÀåÃÊÀ½ÆÄ µð¹ÙÀ̽ºÀÇ ¶Ù¾î³­ ¿µ»ó ó¸® ´É·Â°ú Áø´Ü Á¤È®µµ·Î ÀÎÇØ 2032³â±îÁö 3 ¸®µåÇü ºÎ¹®ÀÇ ÇÚµåÇïµå ½ÉÀåÃÊÀ½ÆÄ µð¹ÙÀ̽º ½ÃÀå Á¡À¯À²Àº Å©°Ô ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ Àåºñ´Â ÷´Ü Æ®·£½ºµà¼­ ±â¼ú°ú Á¤±³ÇÑ ¾Ë°í¸®ÁòÀ» ÅëÇØ ½Ç½Ã°£À¸·Î ½ÉÀåÀÇ 3Â÷¿ø À̹ÌÁö¸¦ »ý¼ºÇÏ¿© ÀÓ»óÀÇ¿¡°Ô ½ÉÀåÀÇ ÇØºÎÇÐÀû ±¸Á¶¿Í ±â´É¿¡ ´ëÇÑ µ¶º¸ÀûÀÎ ÀλçÀÌÆ®À» Á¦°øÇÕ´Ï´Ù. ƯÈ÷ ¼±Ãµ¼º ½ÉÀå ÁúȯÀ̳ª ±¸Á¶Àû ½ÉÀå Áúȯ°ú °°Àº º¹ÀâÇÑ ÁúȯÀÇ °æ¿ì, ½ÉÀåÀÇ ±¸Á¶¸¦ ´Ù°¢µµ·Î º¼ ¼ö ÀÖÀ¸¹Ç·Î º¸´Ù Á¤È®ÇÑ Ä¡·á °èȹÀ» ¼¼¿ì°í Áø´ÜÀÇ ½Å·Ú¼ºÀ» ³ôÀÏ ¼ö ÀÖ½À´Ï´Ù.

¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ÇÚµåÇïµå ½ÉÀåÃÊÀ½ÆÄ µð¹ÙÀ̽º »ê¾÷Àº ±Þ¼ÓÇÑ µµ½ÃÈ­, ÀÇ·á ÀÎÇÁ¶ó È®´ë, ÀÇ·áºñ Áõ°¡¿¡ ÈûÀÔ¾î 2024-2032³â ¾çÈ£ÇÑ ¼ºÀå¼¼¸¦ º¸ÀÏ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. Áß±¹, Àεµ, ÀϺ»°ú °°Àº ±¹°¡¿¡¼­´Â ½ÉÇ÷°ü ÁúȯÀÇ ºÎ´ãÀÌ Áõ°¡Çϰí ÀÖÀ¸¸ç, ÀÌ´Â °í±Þ Áø´Ü ¼Ö·ç¼Ç¿¡ ´ëÇÑ Å« ¼ö¿ä¸¦ âÃâÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ ÀÇ·á ¼­ºñ½º Á¢±Ù¼ºÀ» °³¼±ÇÏ°í ¿¹¹æÀû ½ÉÀåÇÐÀ» Àå·ÁÇϱâ À§ÇÑ Á¤ºÎÀÇ ±¸»óÀº ÀÌ Áö¿ª ½ÃÀå ¼ºÀåÀ» ´õ¿í ÃËÁøÇϰí ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý°ú Á¶»ç ¹üÀ§

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ¾÷°è ÀλçÀÌÆ®

  • ¿¡ÄڽýºÅÛ ºÐ¼®
  • ¾÷°è¿¡ ´ëÇÑ ¿µÇâ¿äÀÎ
    • ÃËÁø¿äÀÎ
      • ¿ø°Ý ȯÀÚ ¸ð´ÏÅ͸µÀÇ ¼ö¿ä Áõ°¡
      • ±â¼úÀÇ Áøº¸
      • ½ÉÇ÷°üÁúȯ ÀÌȯÀ²ÀÇ »ó½Â
      • °í·ÉÈ­ Àα¸ÀÇ Áõ°¡¿Í ÀçÅÃÀÇ·á µ¿Çâ
    • ¾÷°èÀÇ ÀáÀçÀû ¸®½ºÅ© & °úÁ¦
      • ±ÔÁ¦ Áؼö¿Í Ç¥ÁØÈ­
      • ±âÁ¸ ECG ½Ã½ºÅÛ°ú ºñ±³ÇÑ Áø´Ü ´É·ÂÀÇ ÇѰè
  • ¼ºÀå °¡´É¼º ºÐ¼®
  • ±ÔÁ¦ »óȲ
  • ±â¼úÀû Àü¸Á
  • PorterÀÇ »ê¾÷ ºÐ¼®
  • PESTEL ºÐ¼®

Á¦4Àå °æÀï ±¸µµ

  • ¼­·Ð
  • ±â¾÷ Á¡À¯À² ºÐ¼®
  • °æÀï Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º
  • Àü·« Àü¸Á ¸ÅÆ®¸¯½º

Á¦5Àå ½ÃÀå ÃßÁ¤¡¤¿¹Ãø : Á¦Ç°º°, 2018-2032³â

  • ÁÖ¿ä µ¿Çâ
  • Áø´Ü¿ë ECG ±â±â
    • ¾ÈÁ¤½Ã ECG
    • ºÎÇÏ ECG
  • ¸ð´ÏÅ͸µ¿ë ECG µð¹ÙÀ̽º
    • ȦÅÍ ¸ð´ÏÅÍ
    • MCT
    • ¿þ¾î·¯ºí ECG µð¹ÙÀ̽º
    • ±âŸ

Á¦6Àå ½ÃÀå ÃßÁ¤¡¤¿¹Ãø : ¸®µå À¯Çüº°, 2018-2032³â

  • ÁÖ¿ä µ¿Çâ
  • ½Ì±Û ¸®µå À¯Çü
  • 3 ¸®µå À¯Çü
  • 6 ¸®µå À¯Çü
  • 12 ¸®µå À¯Çü
  • ±âŸ

Á¦7Àå ½ÃÀå ÃßÁ¤¡¤¿¹Ãø : ÃÖÁ¾ ¿ëµµº°, 2018-2032³â

  • ÁÖ¿ä µ¿Çâ
  • º´¿ø¡¤Å¬¸®´Ð
  • Áø´Ü ¼¾ÅÍ
  • ¿Ü·¡ ¼ö¼ú ¼¾ÅÍ
  • ÀçÅÃÀÇ·á
  • ±âŸ

Á¦8Àå ½ÃÀå ÃßÁ¤¡¤¿¹Ãø : Áö¿ªº°, 2018-2032³â

  • ÁÖ¿ä µ¿Çâ
  • ºÏ¹Ì
    • ¹Ì±¹
    • ij³ª´Ù
  • À¯·´
    • µ¶ÀÏ
    • ¿µ±¹
    • ÇÁ¶û½º
    • ÀÌÅ»¸®¾Æ
    • ½ºÆäÀÎ
    • ±âŸ À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • Áß±¹
    • ÀϺ»
    • Àεµ
    • È£ÁÖ
    • Çѱ¹
    • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
  • ¶óƾ¾Æ¸Þ¸®Ä«
    • ºê¶óÁú
    • ¸ß½ÃÄÚ
    • ¾Æ¸£ÇîÆ¼³ª
    • ±âŸ ¶óƾ¾Æ¸Þ¸®Ä«
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • »ç¿ìµð¾Æ¶óºñ¾Æ
    • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
    • ¾Æ¶ø¿¡¹Ì¸®Æ®
    • ±âŸ Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«

Á¦9Àå ±â¾÷ °³¿ä

  • AliveCor, Inc.
  • Allengers Medical Systems, Ltd.
  • Biotronik SE & Co. KG
  • Boston Scientific Corporation
  • Fukuda Denshi Co., Ltd.
  • GE HealthCare Technologies Inc.
  • Hill-Rom Holdings, Inc.
  • Koninklijke Philips N.V.
  • Medtronic plc
  • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
KSA 24.05.31

Global Handheld Echocardiography Devices Market will grow at 4.5% CAGR during 2024-2032, driven by the rising prevalence of cardiovascular diseases (CVDs), technological advancements in handheld echocardiography devices, and growing awareness of early detection and monitoring of cardiac conditions.

According to WHO, cardiovascular diseases claim approximately 17.9 million lives annually, becoming the primary cause of death worldwide. With CVDs accounting for a considerable portion of global mortality rates, there is an urgent need for efficient diagnostic tools to enable early detection and intervention. Handheld echocardiography devices offer a portable and accessible solution for healthcare professionals to conduct timely cardiac assessments, thereby facilitating proactive management of CVDs. As the burden of cardiovascular diseases continues to escalate worldwide, fueled by factors such as sedentary lifestyles, unhealthy dietary habits, and aging populations, the demand for handheld echocardiography devices is expected to soar, driving market growth in the coming years.

The Handheld Echocardiography Devices Industry is classified based on product, lead type, end-use, and region.

The monitoring segment will register significant growth by 2032, as echocardiography devices allow for continuous monitoring of cardiac function in various clinical settings, ranging from intensive care units to outpatient clinics. Advancements in sensor technology and data analytics have enabled the development of handheld devices capable of providing comprehensive hemodynamic assessments, including measurement of cardiac output, ejection fraction, and valve function, thereby enhancing segment growth.

The handheld echocardiography devices market share from the 3 leads segment will grow substantially through 2032 due to the superior imaging capabilities and diagnostic accuracy of handheld echocardiography devices. These devices utilize advanced transducer technology and sophisticated algorithms to generate three-dimensional images of the heart in real time, offering clinicians unparalleled insights into cardiac anatomy and function. The ability to visualize cardiac structures from multiple angles enhances diagnostic confidence while facilitating more precise treatment planning, particularly in complex cases such as congenital heart defects and structural heart diseases.

Asia Pacific Handheld Echocardiography Devices Industry will grow at a decent pace between 2024 and 2032, driven by rapid urbanization, expanding healthcare infrastructure, and increasing healthcare expenditure. Countries such as China, India, and Japan are witnessing a growing burden of cardiovascular diseases, creating a significant demand for advanced diagnostic solutions. Moreover, government initiatives aimed at improving access to healthcare services and promoting preventive cardiology are further fueling market growth in the region.

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market scope & definitions
  • 1.2 Base estimates & calculations
  • 1.3 Data collection
  • 1.4 Forecast parameters
  • 1.5 Data validation
  • 1.6 Data sources
    • 1.6.1 Primary
    • 1.6.2 Secondary
      • 1.6.2.1 Paid sources
      • 1.6.2.2 Public sources

Chapter 2 Executive Summary

  • 2.1 Industry 360-degree synopsis

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Increasing demand for remote patient monitoring
      • 3.2.1.2 Advancements in technology
      • 3.2.1.3 Rising cardiovascular disease incidence
      • 3.2.1.4 Increasing aging population and home healthcare trends
    • 3.2.2 Industry pitfalls & challenges
      • 3.2.2.1 Regulatory compliance and standardization
      • 3.2.2.2 Limited diagnostic capability compared to traditional ECG systems
  • 3.3 Growth potential analysis
  • 3.4 Regulatory landscape
  • 3.5 Technological landscape
  • 3.6 Porter's analysis
    • 3.6.1 Supplier power
    • 3.6.2 Buyer power
    • 3.6.3 Threat of new entrants
    • 3.6.4 Threat of substitutes
    • 3.6.5 Industry rivalry
  • 3.7 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

  • 4.1 Introduction
  • 4.2 Company market share analysis
  • 4.3 Competitive positioning matrix
  • 4.4 Strategy outlook matrix

Chapter 5 Market Estimates and Forecast, By Product, 2018 - 2032 ($ Mn)

  • 5.1 Key trends
  • 5.2 Diagnostics ECG machines
    • 5.2.1 Resting ECG
    • 5.2.2 Stress ECG
  • 5.3 Monitoring ECG devices
    • 5.3.1 Holter monitors
    • 5.3.2 Mobile cardiac telemetry (MCT)
    • 5.3.3 Wearable ECG devices
    • 5.3.4 Other devices

Chapter 6 Market Estimates and Forecast, By Lead Type, 2018 - 2032 ($ Mn)

  • 6.1 Key trends
  • 6.2 Single lead type
  • 6.3. 3 lead type
  • 6.4. 6 lead type
  • 6.5. 12 lead type
  • 6.6 Other lead types

Chapter 7 Market Estimates and Forecast, By End-Use, 2018 - 2032 ($ Mn)

  • 7.1 Key trends
  • 7.2 Hospitals & clinics
  • 7.3 Diagnostic centers
  • 7.4 Ambulatory surgical centers
  • 7.5 Home care settings
  • 7.6 Other end-users

Chapter 8 Market Estimates and Forecast, By Region, 2018 - 2032 ($ Mn)

  • 8.1 Key trends
  • 8.2 North America
    • 8.2.1 U.S.
    • 8.2.2 Canada
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 France
    • 8.3.4 Italy
    • 8.3.5 Spain
    • 8.3.6 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 China
    • 8.4.2 Japan
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 South Korea
    • 8.4.6 Rest of Asia Pacific
  • 8.5 Latin America
    • 8.5.1 Brazil
    • 8.5.2 Mexico
    • 8.5.3 Argentina
    • 8.5.4 Rest of Latin America
  • 8.6 Middle East and Africa
    • 8.6.1 Saudi Arabia
    • 8.6.2 South Africa
    • 8.6.3 UAE
    • 8.6.4 Rest of Middle East and Africa

Chapter 9 Company Profiles

  • 9.1 AliveCor, Inc.
  • 9.2 Allengers Medical Systems, Ltd.
  • 9.3 Biotronik SE & Co. KG
  • 9.4 Boston Scientific Corporation
  • 9.5 Fukuda Denshi Co., Ltd.
  • 9.6 GE HealthCare Technologies Inc.
  • 9.7 Hill-Rom Holdings, Inc.
  • 9.8 Koninklijke Philips N.V.
  • 9.9 Medtronic plc
  • 9.10 Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
»ùÇà ¿äû ¸ñ·Ï
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
¸ñ·Ï º¸±â
Àüü»èÁ¦